Clinical trials: Migraine, completed
Migraine
Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)
This study will demonstrate the definitive bioequivalence of a solid dose formulation of MK0974 to the liquid filled capsule formulation of MK0974.
- Trial name
- NCT00966030
- Testing
- MK0974 tablet, Comparator: MK0974 liquid filled capsule
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Merck Sharp & Dohme LLC
Migraine Disorders, Headache
Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea
This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of botulinum toxin Type A to treat Chronic Migraine in clinical practice.
- Trial name
- NCT01976611
- Testing
- botulinum toxin Type A
- Where
- South Korea
- Volunteers
- 402 people
- Sponsor
- Allergan
Migraine With or Without Aura
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
The Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders
- Trial name
- NCT03194555
- Testing
- Low-Dose Naltrexone and Acetaminophen Combination
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Allodynic Therapeutics, Inc
Migraine
MicroRNA Profile and Erenumab Treatment
Erenumab, a monoclonal antibody acting on the calcitonin gene-related peptide (CGRP) receptor, is an effective and safe migraine-specific preventive drug.
- Trial name
- NCT04659226
- Testing
- Blood sampling for microRNA testing
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- University of L'Aquila
Migraine Without Aura
PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
The investigators hypothesized that migraine without patients with many genetic loci associated with migraine (high genetic load) would be more sensitive and get provoked more migraine attacks by PACAP compared to patients with…
- Trial name
- NCT02158221
- Testing
- PACAP
- Where
- Denmark
- Volunteers
- 32 people
- Sponsor
- Danish Headache Center
Migraine
Nasal Cavity Cooling for the Symptomatic Relief of Migraine Headache - a Pilot Study
The aim of the study is to evaluate the effect of self-administered intranasal cooling for the symptomatic relief of migraine headache and associated symptoms in an "at home setting".
- Trial name
- NCT04660864
- Testing
- Nasal cavity cooling device.
- Where
- Sweden
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Lund University
Migraine Headache
MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
A study to evaluate rizatriptan/MK0462 (5 and 10 mg) for the treatment of acute migraine attack and treatment of up to two headache recurrences compared to placebo.
- Trial name
- NCT00897949
- Testing
- rizatriptan benzoate (MK0462)
- Volunteers
- 1,473 people
- Sponsor
- Organon and Co
Chronic Migraine as Defined by Criteria of International Headache Society (IHS)
Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine
The purpose of this study is to determine whether TDCS is an effective prophylactic therapy of chronic migraine.
- Trial name
- Medis (NCT02120326)
- Testing
- Transcranial direct current stimulation of the motor cortex, simulation of Transcranial direct current stimulation of the motor cortex
- Where
- 2 sites in France
- Volunteers
- 36 people
- Sponsor
- University Hospital, Grenoble
Migraine Disorders
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
This study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch.
- Trial name
- NP101-007 (NCT00724815)
- Testing
- NP101 - Sumatriptan iontophoretic transdermal patch
- Where
- 34 sites in United States
- Volunteers
- 530 people
- Sponsor
- NuPathe Inc.
Migraine
The Effect of Cervical Stabilization Training in Individuals With Migraine
Studies examining stabilization training and cervical muscle endurance generally focused on headache as the main topic and did not focus on migraine.
- Trial name
- NCT06991504
- Testing
- Cervical Stabilization Exercises, vestibular exercises, Classic cervical/ neck exercises
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people
- Sponsor
- Zonguldak Bulent Ecevit University
Migraine
The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients
The purpose of this study is to validate the novel hypothesis that daily use of L-cysteine (Acetium® capsules) is an effective means to decrease the frequency of (or completely abort) the headache attacks in migraine patients.
- Trial name
- NCT02315833
- Testing
- Acetium
- Where
- 7 sites in Estonia, Finland
- Volunteers
- 200 people
- Sponsor
- Biohit Oyj
Migraines
A Nutritional Intervention for Migraines-2
The purpose of the study is to assess whether, in individuals with migraines, a low-fat, vegan diet improves pain more effectively than a control supplement or a placebo.
- Trial name
- WCCR-MIG2 (NCT01699009)
- Testing
- Plant based diet, an unrestricted diet
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Physicians Committee for Responsible Medicine
Migraine
Diary-based Study on the Course of Hormone-withdrawal Migraines
Single centered diary-based study to identify course and characteristics of hormone withdrawal headaches/migraines in users of combined hormonal contraceptives Objectives of the Research Project: to identify the course and…
- Trial name
- NCT04012593
- Testing
- Diary
- Where
- Switzerland
- Volunteers
- 47 people, healthy volunteers welcome
- Sponsor
- University of Zurich
Migraine, Cluster Headache
Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache
This is an observational, longitudinal cohort pilot study measuring physiological signals through wearable sensors combined with machine learning algorithms to detect behaviour, stress and headaches in patients with migraine and…
- Trial name
- COPIMAC (NCT04949204)
- Testing
- Wearable sensor detection
- Where
- Belgium
- Volunteers
- 19 people
- Sponsor
- University Hospital, Ghent
Migraine
Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data
The proposed study is a retrospective, non-interventional analysis that uses medical and pharmacy claims data in the US from Komodo Health
- Trial name
- NCT05177406
- Testing
- Aimovig
- Where
- United States
- Volunteers
- 1,839 people
- Sponsor
- Novartis Pharmaceuticals
Migraine With Aura, Migraine Without Aura
Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment
This is a Post-marketing, real-world evidence study investigating the safety and efficacy of the acute treatment of migraine with a Remote Electrical Neuromodulation (REN) device (Nerivio) in migraine patients with and without…
- Trial name
- NCT06023953
- Testing
- Nerivio device
- Where
- Israel
- Volunteers
- 31,715 people
- Sponsor
- Theranica
Migraine Without Aura
The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
The purpose of this study is to determine the effects of antihistamine (Clemastin) on migraines triggered by pituitary adenylate cyclase activating peptide-38 (PACAP38) as well as on biochemical markers for mast cell…
- Trial name
- NCT02364453
- Testing
- PACAP38
- Where
- Denmark
- Volunteers
- 20 people
- Sponsor
- Song Guo
Chronic Migraine
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
The purpose of this study is to understand better the mechanisms of action of calcitonin gene related peptide (CGRP) targeted monoclonal antibodies in migraine prevention.
- Trial name
- NCT04271202
- Testing
- Emgality 120 MG in 1 ML Prefilled Syringe
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- Beth Israel Deaconess Medical Center
Migraine
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
This study is being conducted to evaluate the efficacy of a 91-day extended cycle oral contraceptive compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.
- Trial name
- NCT00781456
- Testing
- 91-day Levonorgestrel Oral Contraceptive
- Where
- 22 sites in United States
- Volunteers
- 109 people
- Sponsor
- Duramed Research
Migraine
The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects
To evaluate pharmacokinetic/pharmacodynamic characteristics and safety of QDX after single oral administration in healthy Korean male subjects
- Trial name
- NCT04401137
- Testing
- Topiramate
- Where
- South Korea
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- SK Chemicals Co., Ltd.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.